| Financial Year |
March 31 2023 |
| Monetary Funds |
568,186,059.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
90,510,893.55 |
| Accounts Receivable |
323,716,814.28 |
| Advances to Suppliers |
39,607,774.22 |
| Other Receivables |
10,833,578.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
586,837,156.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,878,017.25 |
| Total Current Assets |
1,634,961,874.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,857,463.06 |
| Investment Properties |
-- |
| Fixed Assetes |
1,953,985,451.85 |
| Under-construction Projects |
2,179,539.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
353,724,448.70 |
| R&D expenses |
4,986,213.44 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
24,679,422.78 |
| Other Non-Current Assets |
1,128,107.60 |
| Sub-Total of Non-Current Assets |
2,342,540,647.03 |
| Total Assets |
3,977,502,521.86 |
| Short-Term Loans |
2,072,534,129.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
91,992,647.29 |
| Accounts Payable |
538,344,801.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
45,529,257.51 |
| Taxes Payable |
18,064,552.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,481,289.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
89,477,517.20 |
| Other Current Liabilities |
47,653,936.71 |
| Sub-Total of Current Liabilities |
3,018,956,949.33 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
47,405,819.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
77,771,212.05 |
| Deferred Income Tax Liabilities |
5,217,319.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
137,151,180.68 |
| Total Liabilities |
3,156,108,130.01 |
| Paid-In Capital(Or Share Stock) |
797,848,400.00 |
| Capital Surplus |
864,467,357.03 |
| Surplus Reserve |
187,753,923.88 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-946,114,861.10 |
| Minority Stockholder's Interest |
-79,745,528.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
901,139,920.26 |
| Owner's Equity（Stockholder's Equity） |
821,394,391.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,977,502,521.86 |
